Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 3094137)

Published in Scand J Infect Dis on January 01, 1986

Authors

K Roos, E Grahn, S E Holm

Articles by these authors

Resistance to erythromycin in group A streptococci. N Engl J Med (1992) 4.42

Invasive group A streptococcal infections. N Engl J Med (1996) 2.16

Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis (1994) 1.75

Immunoprecipitating factors of vaccinia virus. Virology (1965) 1.60

Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis--a randomized placebo-controlled multicentre study. Scand J Infect Dis (1996) 1.46

Studies on Branhamella Catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis (1976) 1.44

Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection. J Infect Dis (1992) 1.43

Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J Infect Dis (1994) 1.42

Expression of streptococcal plasmid-determined resistance to erythromycin and lincomycin in Escherichia coli. Mol Gen Genet (1981) 1.40

Penetration of antibiotics into the normal and diseased maxillary sinus mucosa. Scand J Infect Dis Suppl (1978) 1.39

[Medical follow-up of drunken drivers reduces relapses dramatically]. Lakartidningen (1992) 1.39

Influence of combinations of oral bacteria on periapical tissues of monkeys. Scand J Dent Res (1982) 1.35

Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun (1994) 1.34

Case of apparent reinfection with rubella. Lancet (1970) 1.31

Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis (1996) 1.31

Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis (1999) 1.30

Acinetobacter calcoaceticus outbreak associated with peritoneal dialysis. Am J Epidemiol (1978) 1.28

Streptococcal anti-group A precipitins in sera from patients with rheumatic arthritis and acute glomerulonephritis. Int Arch Allergy Appl Immunol (1970) 1.27

Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro. J Antimicrob Chemother (1989) 1.27

Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis (1998) 1.26

A 12-residue-long polyleucine tail is sufficient to anchor synaptobrevin to the endoplasmic reticulum membrane. J Biol Chem (1996) 1.25

Density profile of group B streptococci, type III, and its possible relation to enhanced virulence. J Clin Microbiol (1987) 1.21

Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis (1993) 1.21

Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun (1994) 1.21

Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun (1978) 1.17

Properties of high and low density subpopulations of group B streptococci: enhanced virulence of the low density variant. Microb Pathog (1988) 1.16

Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. Scand J Infect Dis (1995) 1.12

Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scand J Infect Dis Suppl (1983) 1.10

Long-term antibiotic treatment of chronic bacterial prostatitis. Effect on bacterial flora. Br J Urol (1989) 1.09

In vitro inhibition of S. pneumoniae, nontypable H. influenzae and M. catharralis by alpha-hemolytic streptococci from healthy children. Int J Pediatr Otorhinolaryngol (1999) 1.08

Some clinical, immunological and bacteriological observations in a case of pyogenic arthritis due to bacteroides fragilis. Scand J Infect Dis (1975) 1.08

Can decreased phagocytosis and killing of autologous gram-positive bacteria explain the finding of gram-positive bacteria in "non-bacterial prostatitis"? Acta Pathol Microbiol Immunol Scand B (1987) 1.07

Molecular cloning in streptococci: physical mapping of the vehicle plasmid pSM10 and demonstration of intergroup DNA transfer. Mol Gen Genet (1981) 1.06

An antigenic relationship between kidney and certain Escherichia coli strains. Int Arch Allergy Appl Immunol (1971) 1.06

Experimental models for studies on transportation of antibiotics to extravasal compartments. Scand J Infect Dis Suppl (1978) 1.05

The prevalence of beta-haemolytic streptococci in throat specimens from healthy children and adults. Implications for the clinical value of throat cultures. Scand J Prim Health Care (1997) 1.04

Reevaluation of experiments intended to demonstrate immunological cross-reactions between mammalian tissues and streptococci. Prog Allergy (1979) 1.04

A chromogenic assay for the detection of plasmin generated by plasminogen activator immobilized on nitrocellulose using a para-nitroanilide synthetic peptide substrate. Anal Biochem (1989) 1.03

Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.02

In-vitro antibacterial activity of SQ 26,776. J Antimicrob Chemother (1981) 1.01

The role of household contacts in the transmission of group A streptococci. Scand J Infect Dis (1997) 1.00

The prevalence of potential pathogenic bacteria in nasopharyngeal samples from healthy children and adults. Scand J Prim Health Care (1998) 1.00

Effects of supra- and sub-MIC benzylpenicillin concentrations on group A beta-haemolytic streptococci during the postantibiotic phase in vivo. J Antimicrob Chemother (1990) 1.00

Purification of immunolobulin G Fc-reactive factor from Streptococcus azgazardah. Acta Pathol Microbiol Scand C (1976) 1.00

Novel coagglutination method for serotyping group B streptococci. J Clin Microbiol (1992) 0.99

Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scand J Infect Dis (1988) 0.98

Pathogenic mechanism of acute post-streptococcal glomerulonephritis. Scand J Infect Dis (1999) 0.97

Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child (2008) 0.97

Penetration of ampicillin and dicloxacillin into tissue cage fluid in rabbits: relation to serum and tissue protein binding. Scand J Infect Dis (1981) 0.97

Allele substitution of the streptokinase gene reduces the nephritogenic capacity of group A streptococcal strain NZ131. Infect Immun (2000) 0.97

Streptokinase as a mediator of acute post-streptococcal glomerulonephritis in an experimental mouse model. Infect Immun (1998) 0.97

Demonstration and characterization of buoyant-density subpopulations of group B Streptococcus type III. J Infect Dis (1990) 0.96

An in vivo model for evaluation of the postantibiotic effect. Scand J Infect Dis (1988) 0.96

The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results. Inhal Toxicol (2010) 0.92

Small-fragment restriction endonuclease analysis in epidemiological mapping of group A streptococci. J Med Microbiol (1994) 0.92

Precipitinogens in beta-hemolytic streptococci and some related human kidney antigens. Acta Pathol Microbiol Scand (1967) 0.91

Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase, and modified nucleosides as biological markers in malignant lymphomas. Recent Results Cancer Res (1983) 0.91

A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles. Inhal Toxicol (2008) 0.90

Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol (1999) 0.90

Interference of alpha-hemolytic streptococci isolated from tonsillar surface on beta-hemolytic streptococci (Streptococcus pyogenes)--a methodological study. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 0.90

Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otorhinolaryngol (1993) 0.89

Chronic maxillary sinusitis. Differential diagnosis and genesis. Acta Otolaryngol (1982) 0.89

Single-dose pharmacokinetics of dicloxacillin in healthy subjects of young and old age. Scand J Infect Dis (1986) 0.89

Bacteria in hip surgery. A study of routine aerobic and anaerobic cultivation from skin and closed suction wound drains. Acta Orthop Scand (1976) 0.88

Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages. Scand J Infect Dis Suppl (1978) 0.87

Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group. Scand J Infect Dis (1995) 0.87

Antigenic factors common to human kidney and nephritogenic and non-nephritogenic streptococcal strains. Int Arch Allergy Appl Immunol (1968) 0.87

Transformation of Streptococcus sanguis (Challis) by linear plasmid molecules. Mol Gen Genet (1982) 0.87

Intraventricular treatment of Serratia marcescens meningitis with gentamicin. Pharmacokinetic studies of gentamicin concentration in one case. Scand J Infect Dis (1976) 0.87

Pharmacodynamic effects of subinhibitory antibiotic concentrations. Scand J Infect Dis Suppl (1990) 0.87

Discrepancy between results of the Streptozyme test and those of the antideoxyribonulcease B and antihyaluronidase tests. J Clin Microbiol (1978) 0.87

Erythromycin-resistant beta-hemolytic streptococci group A in Göteborg, Sweden. Scand J Infect Dis (1988) 0.86

An experimental model for acute poststreptococcal glomerulonephritis in mice. APMIS (1996) 0.86

Killing of Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus by human polymorphonuclear leukocytes in serum and saliva. Oral Microbiol Immunol (1993) 0.86

Inhibition of OM pathogens by alpha-hemolytic streptococci from healthy children, children with SOM and children with rAOM. Int J Pediatr Otorhinolaryngol (2000) 0.86

Chloroform mode of action: implications for cancer risk assessment. Regul Toxicol Pharmacol (1997) 0.85

Identification of domains involved in superantigenicity of streptococcal pyrogenic exotoxin F (SpeF). Microb Pathog (1998) 0.85

Antigenic composition of a vaccine strain of Francisella tularensis. Int Arch Allergy Appl Immunol (1980) 0.85

Cardiac autoantibodies. I. Immunodiffusion analysis of multiple responses evoked homologously and heterologously. J Exp Med (1968) 0.85

Tissue cages for study of experimental streptococcal infection in rabbits. I. Production of erythrogenic toxins in vivo. Immunobiology (1982) 0.85

Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure. Inhal Toxicol (2011) 0.85

Assessment of reproductive effects in largemouth bass (Micropterus salmoides) exposed to bleached/unbleached kraft mill effluents. Arch Environ Contam Toxicol (2001) 0.84

Bacterial contamination and sperm recovery after semen preparation by density gradient centrifugation using silane-coated silica particles at different g forces. Hum Reprod (2000) 0.84

Detection of antibodies to Newcastle disease virus in ostriches (Struthio camelus) by an indirect ELISA. Avian Dis (1998) 0.84

Growth of group B streptococci and development of surface antigens in tissue cages implanted in rabbits. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.84

A prospective, randomized study of amikacin and gentamicin in serious infections with focus on efficacy, toxicity and duration of serum levels above the MIC. J Antimicrob Chemother (1983) 0.84

The prevalence of potential pathogenic bacteria in nasopharyngeal samples from individuals with a respiratory tract infection and a sore throat--implications for the diagnosis of pharyngotonsillitis. Fam Pract (2001) 0.84

Virulence properties of erysipelas-associated group A streptococci. Eur J Clin Microbiol Infect Dis (1992) 0.84

Studies on some variables influencing aminoglycoside efficacy in vivo and in vitro. Scand J Infect Dis (1981) 0.84

High cytokine levels in perforated acute otitis media exudates containing live bacteria. Clin Microbiol Infect (2010) 0.83

Detection and nucleotide sequence analysis of the speC gene in Swedish clinical group A streptococcal isolates. J Clin Microbiol (1994) 0.83

Apical periodontitis induced by selected bacterial strains in root canals of immunized and nonimmunized monkeys. Scand J Dent Res (1982) 0.83